CLINICAL TRIALS PROFILE FOR TRIBENZOR
✉ Email this page to a colleague
All Clinical Trials for TRIBENZOR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02962258 ↗ | BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions | Completed | Torrent Pharmaceuticals Limited | Phase 1 | 2011-05-01 | Subjects to compare the single dose bioavailability of Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets 40+10+25 mg and Tribenzor® 40+10+25 mg Tablets of Daichi Sankyo Inc, USA. Dosing periods of studies were separated by a washout period of 22 days. |
NCT02962336 ↗ | Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions. | Completed | Torrent Pharmaceuticals Limited | Phase 1 | 2011-05-01 | Subjects to compare the single dose bioavailability of Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets 40+10+25 mg and Tribenzor® 40+10+25 mg Tablets of Daichi Sankyo Inc, USA. Dosing periods of studies were separated by a washout period of 22 days. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRIBENZOR
Condition Name
Clinical Trial Progress for TRIBENZOR
Clinical Trial Phase
Clinical Trial Sponsors for TRIBENZOR
Sponsor Name